Objective: The objective of the current trial was to characterize the anxiolytic effect of darigabat in a CO2 inhalation translational model of panic and fear in healthy participants.
Objective: The objective of the current trial was to characterize the anxiolytic effect of darigabat in a CO2 inhalation translational model of panic and fear in healthy participants.
You are now leaving cerevel.com, a website provided by Cerevel Therapeutics. The content displayed on external websites is not controlled by Cerevel, and Cerevel assumes no responsibility for the information or statements on external websites.